News

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology, 2021 Feb;360:104274, doi: 10.1016/j.cellimm.2020.104274

28 December 2020

The MATAO trial for ovarian cancer patients is open for participation

11 December 2020

Discovering Darwin in oncology: Launch of a ‘Request for Application’ for researchers in evolutionary therapy

1 December 2020

RFA letter of intent

RFA letter of intent template

26 November 2020

RFA Funding Guidelines

RFA Funding Guidelines document

26 November 2020

Finding existing drugs potentially active against BRCA mutated breast cancers: a literature based approach

Presented on EBCC-12, the 12th European Breast Cancer Conference

2 October 2020